Clinical Trial Update: Intrathecal Rituximab in Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on intrathecal rituximab for chronic progressive multiple sclerosis has completed recruitment and study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Chronic Progressive

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Centre Hospitalier de PAU | Conditions: Multiple Sclerosis, Chronic Progressive, Nervous System Diseases | Phase 2 | Status: COMPLETED